Effects of Scalp Nerve Block on Postoperative Pain, Hemodynamics and Surgical Stress Response in Craniotomy Surgery

StatusCompleted
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Completed without a posted recruiting period
    • Eligibility criteria expanded, about 19 words
  2. Primary completion date: Jul 28, 2025 to Mar 28, 2026
    • Start date: Jun 30, 2025 to Nov 30, 2025
    • Study completion date: Aug 30, 2025 to May 1, 2026
    v4
  3. Start date: Mar 30, 2025 to Jun 30, 2025
    • Primary completion date: May 28, 2025 to Jul 28, 2025
    • Study completion date: Jun 30, 2025 to Aug 30, 2025
    v3
  4. Start date: Dec 30, 2024 to Mar 30, 2025
    • Primary completion date: Feb 28, 2025 to May 28, 2025
    • Study completion date: Mar 30, 2025 to Jun 30, 2025
    v2
  5. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The hypothesis of this study is that preincisional scalp nerve block will reduce postoperative opioid use and surgical stress response compared to postincisional scalp nerve block in craniotomy surgery with general anesthesia.
Trial Details
NCT Number NCT06748547
Lead Sponsor Umraniye Education and Research Hospital
Conditions
(from sponsor)		 Analgesia, Post Operative Pain
Related terms Agnosia, Postoperative Pain
Enrollment 64 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov